Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Company Profile Theravance Biopharma Inc TBPH

Theravance Biopharma, Inc., a biopharmaceutical company, develops and commercializes medicines in the United States. It offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease (COPD). Its late-stage investigational once-daily norepinephrine reuptake inhibitor, Ampreloxetine is in the development for symptomatic... see more

Showcase News Releases

Showcase news

Globex Mining Enterprises Inc.
Globex Reports Final Drill Hole Results from Rouyn-Merger
Lithium Ionic Corp
Lithium Ionic: 2025 Year in Review - Advancing Toward Construction in Brazil's Lithium Valley
Green Bridge Metals Corporation
Green Bridge Metals Obtains Permit and Signs Contract Agreement to Conduct a Diamond Core Drill Program at Its Titac Deposit

More Showcase News Releases »